We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $3.01M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
43% more capital invested
Capital invested by funds: $2.1M → $3.01M (+$909K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 23 → 22 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
11
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$1.41M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$68.5K |
| 3 |
Renaissance Technologies
New York
|
+$36K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.99K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$85.9K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$35K |
| 3 |
BlackRock
New York
|
-$18.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$17K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$881 |
